Denali Therapeutics Inc
Change company Symbol lookup
Select an option...
DNLI Denali Therapeutics Inc
GAB Gabelli Equity Trust
WTR Aqua America Inc
BAC Bank of America Corp
BBL BHP Group PLC
NOK Nokia Oyj
LMAT LeMaitre Vascular Inc
CXW CoreCivic Inc
SITE SiteOne Landscape Supply Inc
NVDA NVIDIA Corp
Go

Health Care : Biotechnology | Company profile

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately four specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration. The Company’s development programs include Lysosomal Function Pathway, Glial Biology Pathway, and Cellular Homeostasis Pathway. Its product pipeline includes drug candidates such as DNL201, DNL 151, ATV:aSyn, ETV:IDS, DNL747, and ATV:TREM2.

Closing Price
$20.97
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
257,052
0

Stock market ends near session high, buoyed by rally in Microsoft and Apple stocks

4:07 pm ET February 4, 2019 (MarketWatch)
Print

U.S. stock benchmarks on Monday finished the day around the loftiest levels of the session, as technology and internet stocks rallied on the back of strong gains from the likes of Microsoft Corp. (MSFT) and Apple Inc. (AAPL). The Dow Jones Industrial Average rose 175 points, or 0.7%, at 25,239, the S&P 500 index gained 0.7% to reach 2,724, underpinned by a sharp rally in the technology sector (XLK), up 1.6%, on a preliminary basis. The technology-laden Nasdaq Composite Index advanced 1.2% to 7,348, putting the index not far from escaping bear-market territory, commonly defined as a decline of at least 20% from a recent peak. The index entered bear market on Dec. 21 but has climbed nearly 20% from its bear-market low, with such a rise by some measures, representing an emergence from bear market. Looking ahead, market participants were awaiting results from Google-parent Alphabet Inc. (GOOGL)(GOOGL), which were slated for after the close of trading.

-Mark DeCambre; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 04, 2019 16:07 ET (21:07 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.